| Name | Title | Contact Details |
|---|
Crestec USA Inc is a Torrance, CA-based company in the Software and Internet sector.
Socius is an internationally recognized business consulting firm with over 30 years of award-winning experience leveraging technology to accelerate the growth and profitability of small to midsized businesses from our offices in Cincinnati, Cleveland, and Columbus, Ohio, Atlanta, Georgia, Kansas City, Kansas, and San Francisco, California. Through an extensive list of specialized consulting services and an array of software specific solution packages, Socius works to improve your productivity, empower your staff, streamline and automate your business processes, and allow you to better understand and connect with your customers and partners. With more than a thousand implementations of ERP and CRM software applications from Microsoft Dynamics, NetSuite, SYSPRO, and Sage, our business relationships are the best indicator of our experience and demonstrated excellence.
NextLabs is a San Mateo, CA-based company in the Software and Internet sector.
Axcient is a Mountain View, CA-based company in the Software and Internet sector.
As the Device Benefit Management (DBM) leader, IPG provides transparent end-to-end implant management and predictive analytical solutions, establishing the industry standard around cost, quality and safety to drive accessibility and affordability of care. The company has pioneered a unique DBM model which streamlines the management and delivery of implantable devices by working directly with health plans, clinical providers, facilities and medical device manufacturers. IPG delivers implant intelligence surrounding the overall cost and quality of healthcare being delivered, adding transparency and predictability of spend in tandem with the implementation of quality and safety metrics necessary to drive and reward best practices. Through collaborative partnerships that drive physician alignment, and employer and patient satisfaction, this approach ensures that patients receive increased access to affordable and innovative life-saving and life-enhancing device-intensive medical therapies.